UPLOAD Filing
ONCOLYTICS BIOTECH INC
Date: Aug. 27, 2025 · CIK: 0001129928 · Accession: 0000000000-25-009210
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289819
Letter
Re: Oncolytics Biotech Inc. Registration Statement on Form F-3 Filed August 22, 2025 File No. 333-289819 Dear Jared Kelly:
August 27, 2025
Jared Kelly Chief Executive Officer Oncolytics Biotech Inc. 4350 Executive Drive, Suite 325 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Christopher J. Clark, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 27, 2025 Jared Kelly Chief Executive Officer Oncolytics Biotech Inc. 4350 Executive Drive, Suite 325 San Diego, CA 92121 Re: Oncolytics Biotech Inc. Registration Statement on Form F-3 Filed August 22, 2025 File No. 333-289819 Dear Jared Kelly: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christopher J. Clark, Esq. </TEXT> </DOCUMENT>